COM(2018)49 EU - Report
Member States’ transposition of Article 118a of Directive 2001/83/EC on the EC code relating to medicinal products for human use - Main contents
Please note
This page contains a limited version of this dossier in the Parlementaire Monitor.
official title
REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the Member States’ transposition of Article 118a of Directive 2001/83/EC of the European Parliament and the Council of 6 November 2001 on the Community code relating to medicinal products for human use as amended by Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011Legal instrument | Report |
---|---|
reference by COM-number i | COM(2018)49 ![]() |
CELEX number i | 52018DC0049 |
Document | 26-01-2018 |
---|---|
Online publication | 26-01-2018 |
This page is also available in a full version containing the summary of the European Parliament Legislative Observatory, the legal context, other dossiers related to the dossier at hand, the stakeholders involved (e.g. European Commission directorates-general, European Parliament committees, Council configurations and even individual EU Commissioners and Members of the European Parliament) and finally documents of the European Parliament, the Council of Ministers and the European Commission.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.